It has been well documented that ghrelin secretion and expression of GHSR1a was relatively high in various types of tumors including pituitary adenomas, other neuroendocrine cancers, breast carcinomas, and prostate cancer cell lines [45]. This evidence concerns the gene GHRL and neuroendocrine carcinoma.